No Data
No Data
Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)
Carisma Therapeutics, Inc. (NASDAQ:CARM) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), 4D Molecular Therapeutics (FDMT) and Carisma Therapeutics (CARM)
Express News | Carisma Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
Express News | Carisma Anticipates Its Cash And Equivalents Sufficient To Sustain Its Planned Operations Into Q3 Of 2025
Carisma Therapeutics GAAP EPS of -$0.27 Beats by $0.03, Revenue of $9.2M Beats by $5.28M
No Data